Cephalon pays $425 million to settle claims of off-label marketing
Cephalon said it will pay $425 million to settle a US Justice Department investigation into practices of off-label marketing of products including its pain reliever Actiq.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.